Sofia Lysenko’s parents moved to the United States from the Ukraine when she was 3 years old. Today, at 17, some of the biggest American pharmaceutical companies want to team up with this teenage science prodigy because she has created an artificial macromolecule robot that can deliver drugs directly to the brain cells of patients with Alzheimer’s and Parkinson’s. Iryna Matviichuk met with Sofia to learn more. Anna Rice narrates her report.
Sesran skype chat
recent news
- Nigerian company creates taxi system fueled by electric vehicles
- Biden grants $6 billion to Micron to boost chip production
- US communications regulator restores net neutrality annulled under Trump
- US growth slowed sharply last quarter to 1.6%, reflecting economy pressured by high rates
- Popular Indian payment system faces restrictions due to China connections
subscribe via email
our twitter
Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookie Policy
To find out more, including how to control cookies, see here: Cookie Policy